×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RXRX – recursion pharmaceuticals, inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RXRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/2
04:43 pm
rxrx
Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead [Seeking Alpha]
Low
Report
Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead [Seeking Alpha]
2/28
07:02 pm
rxrx
Recursion's REC-4881 Milestone And Cash Runway Shift Risk Reward Profile [Yahoo! Finance]
Low
Report
Recursion's REC-4881 Milestone And Cash Runway Shift Risk Reward Profile [Yahoo! Finance]
2/28
01:30 am
rxrx
Recursion Pharmaceuticals (RXRX) was upgraded by Wall Street Zen from
Low
Report
Recursion Pharmaceuticals (RXRX) was upgraded by Wall Street Zen from
2/26
08:03 am
rxrx
Recursion Pharmaceuticals (RXRX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
Low
Report
Recursion Pharmaceuticals (RXRX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
2/25
05:43 pm
rxrx
Recursion Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
2/25
03:58 pm
rxrx
Recursion Pharmaceuticals (RXRX) had its "neutral" rating reaffirmed by Bank of America Corporation.
Low
Report
Recursion Pharmaceuticals (RXRX) had its "neutral" rating reaffirmed by Bank of America Corporation.
2/25
03:22 pm
rxrx
Recursion Pharmaceuticals Q4: Why My December Buy Call Was Too Optimistic [Seeking Alpha]
Low
Report
Recursion Pharmaceuticals Q4: Why My December Buy Call Was Too Optimistic [Seeking Alpha]
2/25
01:14 pm
rxrx
Recursion (RXRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Recursion (RXRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/25/2026
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
BEAT
Report
-1.8%
recursion pharmaceuticals, inc. - class a
11/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
BEAT
Report
1.6%
recursion pharmaceuticals, inc. - class a
8/5/2025
06:30 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-6.9%
recursion pharmaceuticals, inc. - class a
5/5/2025
06:00 am
RXRX
recursion pharmaceuticals, inc. - class a
MISS
Report
-15.5%
recursion pharmaceuticals, inc. - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/3
12:45 pm
rxrx
Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake
Low
Report
Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake
2/25
06:48 am
rxrx
Form S-8 RECURSION PHARMACEUTICAL
Medium
Report
Form S-8 RECURSION PHARMACEUTICAL
2/25
06:45 am
rxrx
Form 424B5 RECURSION PHARMACEUTICAL
Medium
Report
Form 424B5 RECURSION PHARMACEUTICAL
2/25
06:35 am
rxrx
Form 10-K RECURSION PHARMACEUTICAL For: Dec 31
Low
Report
Form 10-K RECURSION PHARMACEUTICAL For: Dec 31
2/25
06:31 am
rxrx
Form 8-K RECURSION PHARMACEUTICAL For: Feb 25
Low
Report
Form 8-K RECURSION PHARMACEUTICAL For: Feb 25
2/19
07:31 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 17 Filed by: Gibson Christopher
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 17 Filed by: Gibson Christopher
2/19
07:31 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 17 Filed by: Taylor Ben R
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 17 Filed by: Taylor Ben R
2/19
07:31 pm
rxrx
Form 4 RECURSION PHARMACEUTICAL For: Feb 17 Filed by: Khan Najat
Medium
Report
Form 4 RECURSION PHARMACEUTICAL For: Feb 17 Filed by: Khan Najat
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: